The Influence of Perioperative Optimisation to the Hip Arthroplasty Outcomes
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Success of the hip arthroplasty depends on the measures that optimize perioperative conditions.It is planned to evaluate semi-closed loop system in the hip arthroplasty surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFirst Posted
Study publicly available on registry
August 24, 2017
CompletedAugust 28, 2017
August 1, 2017
3.7 years
February 29, 2016
August 25, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
The efficiency of semi-closed loop infusion system
Determine the ratio of doctor's approved and rejected computer suggestions
Before the surgery and 12 hrs postoperatively
Secondary Outcomes (7)
Perioperative blood loss
Before (baseline) the surgery,during surgery and 24hrs postoperatively
Coagulation activity
Before (baseline) the surgery and 24hrs postoperatively
Infused fluid and red blood cell volume
Before the surgery and 24hrs postoperatively
Wound healing
Within 6 days postoperatively
Dosage physical exercise sample
Within 6 days postoperatively
- +2 more secondary outcomes
Study Arms (2)
semi-closed system group
EXPERIMENTALSemi-closed loop infusion system tactic. Programmed iv fluid and blood infusion system ,,Belmont Rapid Infuser" and programmable syringe pump for adrenaline infusion.
control group
EXPERIMENTALRoutine infusion therapy tactic
Interventions
Semi -closed loop infusion system tactic.Use volume loading test twice (before surgery and 12hrs postoperatively). Computer provides advisory hypotension treatment algorithm. Computer provides advisory anemia treatment algorithm. Programmed iv fluid and blood infusions system ,,Belmont Rapid Infuser" and programmable syringe pump for adrenaline infusion.
Routine re-hydration bolus before surgery. Routine treatment of hypotension. Routine treatment of anemia.
Eligibility Criteria
You may qualify if:
- Patients with osteoarthritis of the hip undergoing hip arthroplasty with spinal - epidural anesthesia
- Age \>50 and \<85 years
- ASA (American Society of Anesthesiology Classification) II physical status
- Start of operation no later than 09:00
- Signed informed consent form
You may not qualify if:
- Age \<50 and \>85 yers
- BMI (Body Mass Index) \<20 and \>40 kg/m2
- ASA I and ASA\>II physical status
- History of a bleeding disorder
- Anemia before surgery Hb\<110 g/l
- Intravascular fluid infusion within 24 hours before study
- Diabetes mellitus
- Previous open hip surgery
- Psychiatric illness (intake of other psychiatric medication than selective serotonin reuptake inhibitors)
- Alcohol intake 5 U daily
- Contraindication to spinal - epidural anesthesia
- Surgery not by project surgeon
- Start of operation later than 09:00
- Atrial fibrillation
- Narcotic addiction
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vilnius Universitylead
- Karolinska Institutetcollaborator
- Kaunas University of Technologycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrijauskas Audrius, PhD
Vilnius University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Audrius Andrijauskas PhD , principal investigator, clinical professor
Study Record Dates
First Submitted
February 29, 2016
First Posted
August 24, 2017
Study Start
October 1, 2013
Primary Completion
June 1, 2017
Study Completion
July 1, 2017
Last Updated
August 28, 2017
Record last verified: 2017-08